Leading Global Pharmaceutical Company in India
인도의 선도적인 글로벌 제약회사 | 항레트로바이러스 약물
헤테로는 인도에서 코로나19 입원 환자 치료에 사용되는 렘데시비르 주사제 코비포(COVIFOR)의 제네릭 버전을 출시한 인도 최초의 회사이다. 자세한 내용을 보려면 여기를 클릭하세요.
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Netherlands
- Website
- https://hetero.com
- Categories
- 의약품 제조
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)